InvestorsHub Logo
Followers 5
Posts 1266
Boards Moderated 0
Alias Born 09/03/2002

Re: ace1mc post# 3734

Tuesday, 02/10/2015 12:00:51 PM

Tuesday, February 10, 2015 12:00:51 PM

Post# of 34575
Seems to suggest a "broad" platform which other companies in immuno-oncology boast. One thing I have against TPIV

"The fact that those patients responded regardless of the "type of cancer" they had was a clear indication that this set of epitopes are very well processed and are working exactly as they should in the body."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News